Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

Details for Australian Patent Application No. 2010310956 (hide)

Owner Pfizer Inc.

Inventors Mascitti, Vincent

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2010310956

PCT Pub. Number WO2011/051864

Priority 61/257,140 02.11.09 US; 61/372,938 12.08.10 US

Filing date 21 October 2010

Wipo publication date 5 May 2011

International Classifications

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07H 7/04 (2006.01) Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/051864 Priority application(s): WO2011/051864

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310966-Integrated sensing device for assessing integrity of a rock mass and corresponding method

2010310947-Pelvic splint